Pfizer


Pictures of Pfizer

Videos of Pfizer

October 13, 2010

Pfizer Depression Drug Ineffective, May Be Harmful

Send by Reuters

LONDON, Oct 13 (Reuters) - Pfizer's (PFE.N) antidepressant reboxetine is an "ineffective and potentially harmful" drug and published data on [...]
October 13, 2010

Levetown & Jenkins, LLP Announces An Investigation Of The Acquisition Of King ...

Send by MarketWatch (press release)

Inc. ("King") (NYSE:KG) and its Board of Directors in conjunction with the proposed buyout and acquisition of King by Pfizer, Inc. (NYSE:PFE) . [...]
October 14, 2010

Pfizer To Buy King Pharma

Send by Chemical & Engineering News

Continuing its race to bulk up before a key patent expires, Pfizer has agreed to acquire the specialty drug company King Pharmaceuticals for $3.6 billion. [...]
October 13, 2010

Law Office Of Brodsky & Smith, LLC Announces Investigation Of King Pharmaceuticals

Send by MarketWatch (press release)

proposed acquisition by Pfizer, Inc. Under the terms of the offer, King shareholders would receive cash of $14.25 for each share of King stock they own. [...]
October 09, 2010

Pfizer May Divest Capsugel, Tasocitinib Shines For Psoriasis

Send by Pharma Times

Pfizer has hired Morgan Stanley to conduct the review process, saying it expects to make a further announcement by the end of the first quarter of 2011. [...]
October 12, 2010

Promising Data On Pfizer's New NSCLC Drug

Send by Pharma Times

Pfizer's investigational agent PF-00299804 has shown an ability to prevent disease progression when given as a first-line treatment in patients with [...]
October 13, 2010

Pfizer Will Buy King Pharmaceuticals For $3.6B

Send by The Associated Press

NEW YORK — Pfizer Inc. said Tuesday it will buy a company specializing in pain drugs in a $3.6 billion deal meant to shore up the portfolio of the world's [...]
October 12, 2010

Pfizer Will Buy King Pharmaceuticals For $3.6B

Send by The Associated Press

NEW YORK — Pfizer Inc. said Tuesday it will buy a company specializing in pain drugs in a $3.6 billion deal meant to shore up the portfolio of the world's [...]
October 12, 2010

Drug Makers' Appeal Of Hormone

Send by Wall Street Journal

The lawsuits, which involved more than 100 women, were filed in a Minnesota state court in 2008, but the drug makers, including two Pfizer Inc. subsidiaries [...]
October 14, 2010

Supreme Court Is Undecided On Vaccine Case

Send by Examiner.com

WASHINGTON- Parents who believe their teenage daughter suffered serious health problems due to a Pfizer Inc.'s vaccine she received during her infancy are [...]
October 12, 2010

Lipitor Recall Shares Pallets, Puerto Rico With Tylenol, Glumetza

Send by FiercePharma Manufacturing

Musty odors are at it again, this time driving a Pfizer recall of the cholesterol-fighting blockbuster Lipitor. The drug giant recalled 191000 of the 40-mg, [...]
October 13, 2010

Pfizer Recalling Some Bottles Of Lipitor

Send by KTNV Las Vegas

Pfizer is recalling its 40 milligram bottles of Lipitor over reports of an uncharacteristic odor from the packaging. Pfizer says it's not likely to cause [...]
October 09, 2010

Biocon Strikes Record High On Pfizer Drug Deal Report

Send by India Infoline.com

As per reports, Pfizer would pay $200 million upfront to Biocon for acquiring rights to market the drugs in the United States, the European Union and some [...]
October 12, 2010

King Pharmaceuticals Purchased By Pfizer For $3.6 Billion

Send by All About Top News

Pfizer, the globe's leading pharmaceutical firm, is about to make another huge acquisition as it revealed plans of purchasing King Pharmaceuticals – a [...]
October 12, 2010

Pfizer Lung Cancer Drug Looks Promising In Mid

Send by FierceBiotech

Pfizer's experimental lung cancer drug PF-299 has garnered some positive reviews after the pharma giant unveiled some promising, though preliminary, [...]
October 12, 2010

Pfizer To Pay $3.6 Billion For King Pharmaceuticals

Send by Wall Street Journal (blog)

Pfizer and other Big Pharma companies faced with the patent cliff have pegged animal health as a growth area, spurred by demand in emerging markets. [...]
October 13, 2010

Pfizer Linked With Health Issues

Send by TopNews United Kingdom

A novel study conducted by German researchers unveiled Wednesday claimed the Pfizer's antidepressant reboxetine as completely ineffective and detrimental [...]
October 13, 2010

Pfizer Buy Sparks King Pharma Climb

Send by Forbes

Shares of King Pharmaceuticals are on the rise on Tuesday after Pfizer said today it has agreed to acquire the company for $14.25 per share, or $3.6 billion [...]
October 12, 2010

Pfizer's Knock

Send by MarketWatch

By MarketWatch SAN FRANCISCO (MarketWatch) — Pfizer Inc. laid claim to King Pharmaceuticals, Inc. Tuesday with an offer that couldn't be refused. [...]
October 12, 2010

Pfizer Lipitor Recall 2010: 191000 Bottles Details

Send by Only Kent

It now appears that giant drug company Pfizer has recalled some 191000 bottles of Lipitor, a drug that helps control blood cholesterol and also prevent [...]
October 06, 2010

Fitch Lowers Pfizer Outlook To Negative On Patent Impacts

Send by Wall Street Journal

Fitch Ratings lowered its outlook on Pfizer Inc. (PFE) to negative, saying the effects of upcoming patent expirations on the world's largest drug maker's [...]
October 13, 2010

Pfizer Is Not Paying A Ransom For King

Send by Seeking Alpha

Considering King Pharmaceuticals' (KG) share price has not been anywhere close to $14.25 in the last three years, Pfizer's (PFE) takeover offer will look [...]
October 13, 2010

Heads Up | Pfizer To Acquire King Pharmaceuticals

Send by Kansas City Star

Pfizer says it is paying $14.25 a share for King, which is based in Bristol, Tenn. The Treasury Department on Tuesday auctioned $29 billion in three-month [...]
October 14, 2010

AVIATION: US Airlines' Service Improves

Send by Detroit Free Press

Pfizer said Tuesday that it will buy a company specializing in pain drugs in a $3.6-billion deal meant to shore up the portfolio of the world's largest drug [...]
October 09, 2010

Pfizer Drug Promising In Mid

Send by Reuters

NEW YORK Oct 7 (Reuters) - Pfizer Inc's (PFE.N) experimental drug tasocitinib showed promise in a mid-stage clinical trial for psoriasis, the drugmaker said [...]

Submit article

Name:
E-Mail:
Source:
Article:
Please complete all the fields in order to take your article in consideration.